explore -WSS

explore

author：focus 2025-10-01 17:20:35 - browse：27

accountable care organizations cost saving — Adobe

WASHINGTON — A key Obama-era initiative was supposed to save Medicare money by testing new policies for cutting health care costs. It has so far failed to do so, according to nonpartisan congressional budget experts, and it’s not expected to save money anytime soon.

The 2010 Affordable Care Act created a government center, named the Center for Medicare and Medicaid Innovation, that was given $10 billion over a decade to test new Medicare and Medicaid pay policies. It has since been funded at the same level for another 10 years.

Republicans have attacked the center over the years. Although most of its pilot programs involve lowering hospital spending, some of the center’s initiatives aiming to lower spending on drugs have often provoked GOP ire. Most recently, they attacked the center’s proposal to cut Medicare pay for drugs that receive accelerated approvals. The Trump administration also used pilot programs to cut drug spending, including its failed attempt to tie Medicare drug payments to prices abroad.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： STAT Summit: Meghan O’Rourke on making chronic illness visible

WSS

Why a market frenzy over new weight loss drugs defies logic

Listen: A conversation with researcher Kevin Esvelt on biosecurity

For longer

Questions and answers about ramping up H5N1 bird flu vaccine

Roche acquires Telavant from Roivant, adding experimental IBD treatment

Investigation reveals sickle cell patients pressured into sterilizations

entertainment

explore

leisure time

Supreme Court strikes down use of affirmative action

Questions and answers about ramping up H5N1 bird flu vaccine

Peter Hotez and the public health issue of online harassment

For longer

Dobbs anniversary: the lost opportunity of abortion as health care

Study finds gene variants tied to breast cancer risk in Black women

Cancer drug shortages should be causing more outrage

FDA poised to publish guidelines for clinical trial diversity

How one medical school became remarkably diverse

The problems with dementia villages

entertainment

Reports of telehealth's death have been greatly exaggerated

H5N1 virus can be tracked in retail milk, scientists say

Roche drug slashes death risk in early

Smaller biotechs seek to piggyback on weight loss drug boom

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Wikipedia

hotspot

explore

hotspot